Key Takeaways New research helps explain why cancer of the pancreas doesn't respond well to existing cancer drugsTests of an ...

Nearly all of the patients who responded to the a personalized mRNA pancreatic vaccine are still alive six years later.

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, ...

Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...

April is National Donate Life Month, and it hits particularly close to home for the Heat. Alonzo Mourning, one of Miami’s all ...

As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

Pancreatic cancer remains one of the deadliest diagnoses in oncology. Only about 13% of patients survive five years, and for ...

Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...

Patrick Swayze’s widow, Lisa Niemi Swayze, is sharing her thoughts on the upcoming Dirty Dancing sequel. “I actually got to ...

A new drug, Elraglusib, has doubled the survival rate for patients with pancreatic cancer, giving hope and extra time to ...

When most people think about insulin resistance, sugar is usually the first thing that comes to mind. And while excessive ...